Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    18421054 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI.
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases resection;   Drug: Bevacizumab;   Drug: 5 FU;   Drug: Oxaliplatin;   Drug: Irinotecan
2 Recruiting Efficacy And Safety Of Xeliri + Avastin Followed By Xelox + Avastin Or Reverse Sequence In Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Interventions: Drug: Capecitabine;   Drug: Bevacizumab;   Drug: Oxaliplatin;   Drug: Irinotecan
3 Recruiting Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Condition: Metastatic Colorectal Cancer
Interventions: Procedure: Metastases Resection;   Drug: 5-Fluorouracile;   Drug: leucovorin L;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Cetuximab
4 Completed Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy
Condition: Rectal Cancer
Intervention: Drug: preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine
5 Recruiting Genistein in Treatment of Metastatic Colorectal Cancer
Conditions: Colon Cancer;   Rectal Cancer;   Colorectal Cancer
Intervention: Drug: Genistein
6 Active, not recruiting Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab
Conditions: Colorectal Cancer;   Metastasis
Intervention: Biological: Bevacizumab + blood samples

Indicates status has not been verified in more than two years